Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The study is designed as a single-center, prospective, interventional, non-pharmacological, randomized, open-label, controlled trial with parallel groups. It targets patients with prostate cancer or kidney cancer who are candidates for robot-assisted surgical treatment, specifically radical prostatectomy (RP) or partial nephrectomy (PN).
Official title: HUGO RAS Robotic Platform for Radical Prostatectomy and Partial Nephrectomy: Comparison with the Da Vinci Robotic Platform
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
800
Start Date
2025-03-31
Completion Date
2033-03-01
Last Updated
2025-02-25
Healthy Volunteers
No
Interventions
Radical prostatectomy
Radical prostatectomy performed using the Da Vinci Xi and the HUGO RAS platform
Partial nephrectomy
partial nephrectomy (PN) using either the Da Vinci Xi platform or the HUGO™ RAS platform
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy